GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 205 filers reported holding GENMAB A/S in Q3 2021. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $205,483 | -3.6% | 5,826 | +15.9% | 0.00% | 0.0% |
| Q4 2022 | $213,087 | +80.6% | 5,028 | +86.8% | 0.00% | +50.0% |
| Q3 2021 | $118,000 | +9.3% | 2,692 | +1.9% | 0.00% | 0.0% |
| Q2 2021 | $108,000 | +33.3% | 2,642 | +6.6% | 0.00% | 0.0% |
| Q1 2021 | $81,000 | -13.8% | 2,479 | +6.7% | 0.00% | -33.3% |
| Q4 2020 | $94,000 | +14.6% | 2,324 | +4.0% | 0.00% | +50.0% |
| Q3 2020 | $82,000 | +32.3% | 2,235 | +22.5% | 0.00% | 0.0% |
| Q2 2020 | $62,000 | +416.7% | 1,825 | +223.6% | 0.00% | – |
| Q1 2020 | $12,000 | -36.8% | 564 | -33.7% | 0.00% | – |
| Q4 2019 | $19,000 | – | 851 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 242,848 | $9,169,940 | 3.80% |
| Capricorn Fund Managers Ltd | 110,643 | $4,177,880 | 1.28% |
| Arlington Capital Management, Inc. | 35,591 | $1,343,916 | 1.26% |
| XY Capital Ltd | 76,884 | $2,903,140 | 1.13% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 88,000 | $3,322,880 | 0.93% |
| TORRAY INVESTMENT PARTNERS LLC | 110,807 | $4,184,072 | 0.75% |
| Hardman Johnston Global Advisors LLC | 585,139 | $22,094,849 | 0.72% |
| Yorktown Management & Research Co Inc | 16,600 | $626,816 | 0.68% |
| First Light Asset Management, LLC | 160,025 | $6,042,544 | 0.54% |
| MIRABELLA FINANCIAL SERVICES LLP | 28,260 | $2,505,855 | 0.38% |